Cargando…
Decreased Cytokine Plasma Levels and Changes in T-Cell Activation Are Associated With Hemodynamic Improvement and Clinical Outcomes After Percutaneous Mitral Commissurotomy in Patients With Rheumatic Mitral Stenosis
Mitral stenosis (MS) is a consequence of rheumatic heart disease that leads to heart failure requiring mechanical intervention. Percutaneous mitral commissurotomy (PMC) is the treatment of choice for the intervention, and currently there are no soluble markers associated with hemodynamic improvement...
Autores principales: | Silva, Vicente R., Neves, Eula G. A., Passos, Lívia S. Araújo, Cristina de Melo, Flávia, Teixeira-Carvalho, Andrea, Nassif, Maria Cecília L., Junqueira, Lucas Lodi, Aikawa, Elena, Dutra, Walderez O., Nunes, Maria Carmo P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888299/ https://www.ncbi.nlm.nih.gov/pubmed/33614739 http://dx.doi.org/10.3389/fcvm.2020.604826 |
Ejemplares similares
-
Echocardiographic assessment before and after Percutaneous Transvenous Mitral Commissurotomy in patients with Rheumatic Mitral Stenosis
por: Khan, Adnan, et al.
Publicado: (2021) -
Percutaneous Transluminal Mitral Commissurotomy in Pregnant Women with Severe Mitral Stenosis
por: Firouzi, Ata, et al.
Publicado: (2019) -
Raising awareness for rheumatic mitral valve disease
por: Passos, Livia S.A., et al.
Publicado: (2020) -
Successful Treatment of Double-Orifice Mitral Stenosis with Percutaneous Balloon Mitral Commissurotomy
por: Patted, Suresh V., et al.
Publicado: (2012) -
Mid-term (up to 12 years) clinical and echocardiographic outcomes of percutaneous transvenous mitral commissurotomy in patients with rheumatic mitral stenosis
por: Dadjo, Yahya, et al.
Publicado: (2021)